Sharif M Ridwan1, Ferris El-Tayyeb1, James F Hainfeld2, Henry M Smilowitz1. 1. Department of Cell Biology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA. 2. Nanoprobes, Inc., 95 Horseblock Road, Unit 1, Yaphank, NY 11980, USA.
Abstract
Aim: To analyze the localization, distribution and effect of iodine nanoparticles (INPs) on radiation therapy (RT) in advanced intracerebral gliomas over time after intravenous injection. Materials & methods: Luciferase/td-tomato expressing U87 human glioma cells were implanted into mice which were injected intravenously with INPs. Mice with gliomas were followed for tumor progression and survival. Immune-stained mouse brain sections were examined and quantified by confocal fluorescence microscopy. Results: INPs injected intravenously 3 days prior to RT, compared with 1 day, showed greater association with CD31-staining structures, accumulated inside tumor cells more, covered more of the tumor cell surface and trended toward increased median survival. Conclusion: INP persistence and redistribution in tumors over time may enable greater RT enhancement and clinically relevant hypo-fractionated-RT and may enhance INP efficacy.
Aim: To analyze the localization, distribution and effect of iodine nanoparticles (INPs) on radiation therapy (RT) in advanced intracerebral gliomas over time after intravenous injection. Materials & methods: Luciferase/td-tomato expressing U87humanglioma cells were implanted into mice which were injected intravenously with INPs. Mice with gliomas were followed for tumor progression and survival. Immune-stained mouse brain sections were examined and quantified by confocal fluorescence microscopy. Results: INPs injected intravenously 3 days prior to RT, compared with 1 day, showed greater association with CD31-staining structures, accumulated inside tumor cells more, covered more of the tumor cell surface and trended toward increased median survival. Conclusion: INP persistence and redistribution in tumors over time may enable greater RT enhancement and clinically relevant hypo-fractionated-RT and may enhance INP efficacy.
Authors: Victor M Lu; Panogiotis Kerezoudis; Desmond A Brown; Terry C Burns; Alfredo Quinones-Hinojosa; Kaisorn L Chaichana Journal: J Neurooncol Date: 2019-03-27 Impact factor: 4.130
Authors: James F Hainfeld; Henry M Smilowitz; Michael J O'Connor; Farrokh Avraham Dilmanian; Daniel N Slatkin Journal: Nanomedicine (Lond) Date: 2012-12-24 Impact factor: 5.307
Authors: Jeffrey R Ashton; Katherine D Castle; Yi Qi; David G Kirsch; Jennifer L West; Cristian T Badea Journal: Theranostics Date: 2018-02-12 Impact factor: 11.600
Authors: Henry M Smilowitz; Alexandria Meyers; Khalil Rahman; Nathaniel A Dyment; Dan Sasso; Crystal Xue; Douglas L Oliver; Alexander Lichtler; Xiaomeng Deng; Sharif M Ridwan; Lauren J Tarmu; Qian Wu; Andrew L Salner; Ketan R Bulsara; Daniel N Slatkin; James F Hainfeld Journal: Int J Nanomedicine Date: 2018-07-04